- Trials with a EudraCT protocol (24)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
24 result(s) found for: Confusion Assessment Method.
Displaying page 1 of 2.
EudraCT Number: 2014-003385-24 | Sponsor Protocol Number: 2815 | Start Date*: 2016-09-28 |
Sponsor Name:GGZ inGeest, parner VUmc | ||
Full Title: The Recall-study: Rivastigmine for ECT-induced Cognitive Adverse effects in Late Life Depression: a multicenter, randomized, double-blind, placebo-controlled, crossover trial | ||
Medical condition: Interictal delirium during electric convulsive therapy- course | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000823-15 | Sponsor Protocol Number: NEUPRODEX | Start Date*: 2013-12-23 |
Sponsor Name:Charité – Universitätsmedizin Berlin | ||
Full Title: Neuroprotection with Dexmedetomidine in patients undergoing elective cardiac or abdominal surgery | ||
Medical condition: The drug Dexmedetomidine will be investigated in patients (men and women) undergoing elective cardiac or abdominal surgery. The study medication will be administered perioperatively by intravenous ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-004434-32 | Sponsor Protocol Number: PREPOD | Start Date*: 2007-02-06 |
Sponsor Name:Technische Universität München, Fakultät für Medizin, Klinikum rechts der Isar | ||
Full Title: Prevention of postoperative delirium with donepezil | ||
Medical condition: Postoperative delirium | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006221-14 | Sponsor Protocol Number: AM-KS-III/06/08 | Start Date*: 2010-04-06 | |||||||||||
Sponsor Name:Company: Dr. Franz Köhler Chemie GmbH | |||||||||||||
Full Title: Wirksamkeit und Verträglichkeit von Physostigminsalicylat zur Behandlung des post-operativen Delirs nach Aorto-Koronarer-Bypass-Operation. Eine prospektive, doppelblinde, randomisierte, placebo... | |||||||||||||
Medical condition: Patients with postoperative delirium in the termination phase of anaesthesia after ACVB or aortic valve/mitral valve surgery or double heart intervention (heart-lung-machine (HLM) and mild hypother... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007237-47 | Sponsor Protocol Number: PHYDELIO | Start Date*: 2009-01-15 |
Sponsor Name:Charité - Universitätsmedizin Berlin | ||
Full Title: Perioperative physostigmine prophylaxis for liver resection patients at risk for delirium and postoperative cognitive dysfunction Perioperative Gabe von Physostigmin bei Leberteilresktion zur Prop... | ||
Medical condition: The drug physostigmine will be investigated in patients (men and women)undergoing a liver resection. The study medication will be administered by intravenous infusion continuously (24 hours) to pre... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-002316-12 | Sponsor Protocol Number: SR052012 | Start Date*: 2012-08-14 |
Sponsor Name:University Hospitals of the KU Leuven | ||
Full Title: The safety and feasibility of administering xenon to patients undergoing off-pump coronary artery bypass graft surgery: a pilot study XOPCAB – Xenon in Off-Pump Coronary Artery Bypass Grafting | ||
Medical condition: Xenon anesthesia in cardiac surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000485-11 | Sponsor Protocol Number: SR022013 | Start Date*: 2013-04-24 |
Sponsor Name:University Hospitals of the KU Leuven | ||
Full Title: Xenon as an adjuvant to propofol anaesthesia in patients undergoing off-pump coronary artery bypass graft surgery: a randomized controlled trial | ||
Medical condition: Xenon anesthesia in cardiac surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-002586-34 | Sponsor Protocol Number: STEROID_MC_1 | Start Date*: 2020-11-12 | |||||||||||||||||||||||||||||||
Sponsor Name:Department of Anesthesiology, Copenhagen University Hospital Hvidovre, Capital Region of Denmark | |||||||||||||||||||||||||||||||||
Full Title: The effects of preoperative high-dose Dexamethasone on inflammatory response and recovery after emergency laparotomy, a randomized, double-blind, placebo-controlled clinical trial - AHA STEROID ... | |||||||||||||||||||||||||||||||||
Medical condition: Patients undergoing emergency laparotomy due to either Intestinal obstruction or perforated abdominal viscus. | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000262-20 | Sponsor Protocol Number: DPOD III | Start Date*: 2007-07-25 | |||||||||||
Sponsor Name:Stanmore Clinical Research Facility Ltd | |||||||||||||
Full Title: A phase III, 7 days randomised, double-blind, placebo-controlled, parallel group study to assess efficacy of DPZ for reducing the symptoms of post-operative delirium after an elective hip or knee r... | |||||||||||||
Medical condition: Post-operative delirium. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002492-29 | Sponsor Protocol Number: 1928376455 | Start Date*: 2014-10-10 | |||||||||||||||||||||
Sponsor Name:Department of anaesthesia and intensive care, Hvidovre Hospital | |||||||||||||||||||||||
Full Title: The effect of Single-Dose Glucocorticoid on Postoperative delirium among Elderly Hip Fracture Patientes: A Randomized Placebo Controlled Study | |||||||||||||||||||||||
Medical condition: Postoperative Delirium | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004698-15 | Sponsor Protocol Number: S60859 | Start Date*: 2021-05-03 |
Sponsor Name:UZ Leuven / KU Leuven | ||
Full Title: Brain Injury and Ketamine: a prospective, randomized controlled double blind clinical trial to study the effects of ketamine on Therapy Intensity Level and intracranial pressure in acute brain inju... | ||
Medical condition: Traumatic Brain Injury patients requiring sedation to control the intracranial pressure (ICP). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003115-20 | Sponsor Protocol Number: 848041001 | Start Date*: 2018-02-19 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Erasmus Medical Center Rotterdam | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients: a prospective randomised multicenter double-blind placebo-controlled clinical trial | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Delirium | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000805-26 | Sponsor Protocol Number: PSYKFORSK_MAT-MDD | Start Date*: 2021-11-19 |
Sponsor Name:Østfold Hospital Trust | ||
Full Title: An Open-Label, Phase 2, Feasibility Study of Manualized MDMA-Assisted Psychotherapy in Subjects with Major Depressive Disorder | ||
Medical condition: Major Depressive Disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001086-32 | Sponsor Protocol Number: 19-001_AMG | Start Date*: 2020-01-02 |
Sponsor Name:RWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty | ||
Full Title: ADVANCE-CSX Pilot – Antioxidant Treatment with Vitamin C in Cardiac Surgery Patients – a Clinical Pilot Study | ||
Medical condition: Patients undergoing high-risk open-heart surgery with the use of cardiopulmonary bypass (CPB) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-000539-29 | Sponsor Protocol Number: 2018.02.08 | Start Date*: 2018-12-11 | |||||||||||||||||||||
Sponsor Name:Hamilton Health Sciences Corporation | |||||||||||||||||||||||
Full Title: PeriOperative ISchemic Evaluation-3 (POISE-3) Trial | |||||||||||||||||||||||
Medical condition: The occurrence of life-threatening, major, and critical organ bleeding, and, major arterial and venous thrombosis in patients undergoing noncardiac surgery. And for patients in the blood pressure m... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Completed) DK (Completed) AT (Completed) NL (Completed) IT (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-005618-32 | Sponsor Protocol Number: 2021-HJEPharma-002 | Start Date*: 2022-06-29 | |||||||||||||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||||||||||||
Full Title: Dexamethasone, olanzapine, flow-targeted versus pressure-targeted hemodynamic management, and low tidal volume ventilation in patients undergoing on-pump cardiac surgery – a multifactorial design r... | |||||||||||||||||||||||
Medical condition: We investigate the efficacy of two pharmaceutical interventions for reducing mortality and organ damage, and shortening length of hospital stay in patients undergoing heart surgery (i.e. coronary a... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000171-16 | Sponsor Protocol Number: KCH-PRO:19/001 | Start Date*: 2019-08-02 | |||||||||||
Sponsor Name:King's College Hospital NHS Foundation Trust | |||||||||||||
Full Title: Comparison between Propofol and Inhalational Anaesthetic Agents on Cardiovascular Outcomes following Cardiac Surgery - a Randomised Controlled Feasibility Trial | |||||||||||||
Medical condition: Cardiopulmonary bypass (CPB) and revascularisation-induced ischaemic reperfusion injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002584-27 | Sponsor Protocol Number: AC-054-301 | Start Date*: 2007-11-07 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd. | |||||||||||||
Full Title: A prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-caus... | |||||||||||||
Medical condition: Indication: Aneurysmal subarachnoid hemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) FI (Completed) SE (Completed) DE (Completed) AT (Completed) DK (Completed) ES (Completed) CZ (Completed) IT (Completed) SI (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001645-12 | Sponsor Protocol Number: ALPHA2PREVENT | Start Date*: 2021-06-28 |
Sponsor Name:Oslo University Hospital | ||
Full Title: Alpha 2 adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): randomised controlled trial. | ||
Medical condition: Postoperative delirium and cognitive decline in male and female participants aged 70+ scheduled for open heart surgery | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001996-33 | Sponsor Protocol Number: CD12_COVID-19 | Start Date*: 2020-08-26 | |||||||||||
Sponsor Name:CytoDyn, Inc. | |||||||||||||
Full Title: A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients with Severe or Critical Coronavirus Disease 2019 (CO... | |||||||||||||
Medical condition: Coronavirus Disease 2019 (COVID-19) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
